
Sign up to save your podcasts
Or


In this special Science and U interview, Professor Michael Lisanti, Chair of Translational Medicine at the University of Salford, returns to speak with David Gornoski, Tucker Goodrich, and Dr. Weiping Yu. The conversation centers around Dr. Lisanti's fascinating method of fighting metastatic cancer cells with antibiotics like Doxycycline and Bedaquiline. How does Dr. Lisanti's way of treating cancer differ from the common approach and why is it so groundbreaking? How does this approach turn off ATP production without the toxicity associated with the general approach? Listen to the full podcast to find out.
Read Prof. Lisanti's Nature paper here. Read Tucker Goodrich's fascinating blog here. For more content by David Gornoski visit aneighborschoice.com
By David Gornoski4.7
138138 ratings
In this special Science and U interview, Professor Michael Lisanti, Chair of Translational Medicine at the University of Salford, returns to speak with David Gornoski, Tucker Goodrich, and Dr. Weiping Yu. The conversation centers around Dr. Lisanti's fascinating method of fighting metastatic cancer cells with antibiotics like Doxycycline and Bedaquiline. How does Dr. Lisanti's way of treating cancer differ from the common approach and why is it so groundbreaking? How does this approach turn off ATP production without the toxicity associated with the general approach? Listen to the full podcast to find out.
Read Prof. Lisanti's Nature paper here. Read Tucker Goodrich's fascinating blog here. For more content by David Gornoski visit aneighborschoice.com

565 Listeners

440 Listeners

3,363 Listeners

2,277 Listeners

961 Listeners

1,157 Listeners

37 Listeners

770 Listeners

333 Listeners

488 Listeners

373 Listeners

2,163 Listeners

294 Listeners

509 Listeners

166 Listeners